Lizzy, I don't. According to Funny, DRL is undercutting Hikma's price. That might be true. It still doesn't explain to me how the supply for the DRL generic would appear to be increasing while Hikma is stuck at 12000 per week. I know both companies have contracts with CCSB. Does DRL have something else on the side? Sleven,
Market Data 
Markets 
AI
